Geoffrey Peter Herzig, MD (1941-2013): Transplant Pioneer
Managing Hodgkin lymphoma relapsing after autologous hematopoietic cell transplantation: a not-so-good cancer after all!
Conditioning regimens in allo-SCT for thalassemia major
Donor-derived CD4+/CCR7+ T-cell partial selective depletion does not alter acquired anti-infective immunity
Preemptive DLI without withdrawal of immunosuppression to promote complete donor T-cell chimerism results in favorable outcomes for high-risk older recipients of alemtuzumab-containing reduced-intensity unrelated donor allogeneic transplant: a prospective phase II trial
Stable long-term pulmonary function after fludarabine, antithymocyte globulin and i.v. BU for reduced-intensity conditioning allogeneic SCT
Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndrome
Impact of sex incompatibility on the outcome of single-unit cord blood transplantation for adult patients with hematological malignancies
Apoptotic signaling through Fas and TNF receptors ameliorates GVHD in mobilized peripheral blood grafts
Risk stratification of organ-specific GVHD can be improved by single-nucleotide polymorphism-based risk models
In a 12-allele analysis HLA-DPB1 matching is associated with improved OS in leukaemic and myelodysplastic patients receiving myeloablative T-cell-depleted PBSCT from unrelated donors
High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation
Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma
Pre-transplant MRD predicts outcome following reduced-intensity and myeloablative allogeneic hemopoietic SCT in AML
Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus
Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study
Inhibition of S100A6 induces GVL effects in MLL/AF4-positive ALL in human PBMC-SCID mice
Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHD
Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA study
Splenectomy as a measure to treat prolonged post-transplant cytopenia associated with hypersplenism
Treatment of poor graft function after allogeneic hematopoietic cell transplantation with a booster of CD34-selected cells infused without conditioning
A strategy to reduce donor-specific HLA Abs before allogeneic transplantation
Infused neutrophil dose and haematopoietic recovery in patients undergoing autologous transplantation
MTHFR C677T/A1298C genotype: a possible risk factor for liver sinusoidal obstruction syndrome
Blood and marrow transplantation long-term management: prevention and complications